His primary scientific interests are in Carcinogen, DNA, Biochemistry, Adduct and Endocrinology. His Carcinogen research is multidisciplinary, incorporating perspectives in Molecular biology, Genotoxicity, Metabolism and Pyrene. His DNA study combines topics in areas such as Chromatography, Tandem mass spectrometry, Stereochemistry and Cancer research.
His Biochemistry course of study focuses on Bacteria and Mutation frequency. Frederick A. Beland combines subjects such as Acetylation and In vivo with his study of Adduct. His Endocrinology research incorporates themes from Internal medicine, Adenoma and DNA methyltransferase.
Frederick A. Beland mainly focuses on Carcinogen, Biochemistry, DNA, Adduct and Molecular biology. Frederick A. Beland has researched Carcinogen in several fields, including Carcinogenesis, In vivo, Internal medicine and Endocrinology. His research integrates issues of microRNA, Epigenetics and DNA methylation in his study of Carcinogenesis.
His DNA research integrates issues from Chromatography, In vitro, Nucleotide and Benzopyrene. His studies examine the connections between Adduct and genetics, as well as such issues in Stereochemistry, with regards to Guanosine. His Molecular biology research incorporates elements of Cell growth, DNA damage, Mutation, Micronucleus test and Genotoxicity.
His primary areas of investigation include Carcinogen, Cancer research, Pharmacology, Epigenetics and Internal medicine. His Carcinogen research is multidisciplinary, incorporating elements of Molecular biology, In vivo, DNA and Genotoxicity. The concepts of his Cancer research study are interwoven with issues in Carcinogenesis, Cancer, microRNA and Transfection.
His Pharmacology research integrates issues from Metabolite and Apoptosis. His studies in Epigenetics integrate themes in fields like H3K4me3, Histone and DNA methylation. As a part of the same scientific study, he usually deals with the Internal medicine, concentrating on Endocrinology and frequently concerns with Fatty liver, Nonalcoholic fatty liver disease and Receptor.
His primary areas of study are Carcinogen, Cancer research, microRNA, Cancer and Carcinogenesis. His studies deal with areas such as Molecular biology, Ovary and Harderian gland, Pathology as well as Carcinogen. In his study, Biochemistry is inextricably linked to Bladder cancer, which falls within the broad field of Molecular biology.
The various areas that Frederick A. Beland examines in his Cancer research study include Nonalcoholic fatty liver disease and Epigenetics. His microRNA study incorporates themes from Drug toxicity, Drug and Bioinformatics. His Carcinogenesis research includes elements of Tobacco smoke, Mutation, Cancer cell, Genome and Breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe vera.
Boudreau;Beland Fa.
Journal of Environmental Science and Health Part C-environmental Carcinogenesis & Ecotoxicology Reviews (2006)
Malachite Green: A Toxicological Review
Sandra J. Culp;Frederick A. Beland.
Journal of the American College of Toxicology (1996)
Benzo[a]pyrene-nucleic acid derivative found in vivo: structure of a benzo[a]pyrenetetrahydrodiol epoxide-guanosine adduct
A. M. Jeffrey;K. W. Jennette;S. H. Blobstein;I. B. Weinstein.
Journal of the American Chemical Society (1976)
A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay.
Sandra J. Culp;David W. Gaylor;Winslow G. Sheldon;Lawrence S. Goldstein.
Carcinogenesis (1998)
DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice.
Goncalo Gamboa Da Costa;Mona I. Churchwell;L. Patrice Hamilton;Linda S. Von Tungeln.
Chemical Research in Toxicology (2003)
Toxicity and metabolism of malachite green and leucomalachite green during short-term feeding to Fischer 344 rats and B6C3F1 mice.
Sandra J. Culp;Lonnie R. Blankenship;Donna F. Kusewitt;Daniel R. Doerge.
Chemico-Biological Interactions (1999)
Formation and persistence of arylamine DNA adducts in vivo.
Frederick A. Beland;Fred F. Kadlubar.
Environmental Health Perspectives (1985)
DNA hypomethylation in the origin and pathogenesis of human diseases
Igor P. Pogribny;Frederick A. Beland.
Cellular and Molecular Life Sciences (2009)
Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis.
Frederick A. Beland;David T. Beranek;Kenneth L. Dooley;Robert H. Heflich.
Environmental Health Perspectives (1983)
E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells†‡
Volodymyr P. Tryndyak;Frederick A. Beland;Igor P. Pogribny.
International Journal of Cancer (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Center for Toxicological Research
United States Food and Drug Administration
United States Food and Drug Administration
Texas A&M University
National Institutes of Health
United States Food and Drug Administration
University of Chicago
University of Lethbridge
King's College London
International Agency For Research On Cancer
Microsoft (United States)
University of Chicago
Dalian University of Technology
University of Manchester
University of British Columbia
University of Washington
University of Alabama at Birmingham
Nestlé (Switzerland)
University of Virginia
University of Bern
Washington University in St. Louis
University of Michigan–Ann Arbor
Garvan Institute of Medical Research
Harvard University
Children's Hospital of Philadelphia
Vrije Universiteit Brussel